Evidence map›Paper›PMID 35205088›Full record

ArticleBiology2022

Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis.

Lukasz Szarpak, Malgorzata Mierzejewska, Jonasz Jurek, Anna Kochanowska, Aleksandra Gasecka, Zenon Truszewski, Michal Pruc, Natasza Blek, Zubaid Rafique, Krzysztof J Filipiak and 2 more

Abstract read
In one paragraph

Article in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lukasz SzarpakInstitute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, 03-411 Warsaw, Poland.ORCID 0000-0002-0973-5455
Malgorzata Mierzejewska1st Chair and Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-2728-1872
Jonasz Jurek1st Chair and Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0001-9567-8663
Anna Kochanowska1st Chair and Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Aleksandra Gasecka1st Chair and Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Zenon TruszewskiDepartment of Emergency Medicine, Medical University of Warsaw, 02-005 Warsaw, Poland.
Michal PrucResearch Unit, Polish Society of Disaster Medicine, 05-806 Warsaw, Poland.ORCID 0000-0002-2140-9732
Natasza BlekInstitute of Clinical Medicine, Maria Sklodowska-Curie Medical Academy, 04-311 Warsaw, Poland.ORCID 0000-0002-3213-7330
Zubaid RafiqueHenry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Krzysztof J FilipiakInstitute of Clinical Medicine, Maria Sklodowska-Curie Medical Academy, 04-311 Warsaw, Poland.ORCID 0000-0002-6563-0877
Andrea DenegriCardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41121 Modena, Italy.
Milosz J Jaguszewski1st Department of Cardiology, Medical University of Gdansk, 80-294 Gdansk, Poland.ORCID 0000-0002-2555-593X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary artery disease (CAD) is the leading cause of death worldwide. Patients with pre-existing CAD were shown to have a more severe course of COVID-19, but this association has not been clarified. We performed a meta-analysis to determine the association between CAD and COVID-19 outcomes. We searched Scopus, Medline (PubMed), Web of Science, Embase, and Cochrane databases up to 2 November 2021. There were 62 studies with a total population of 49,286 patients included in the meta-analysis. CAD occurrence in survivor vs. non-survivor groups varied and amounted to 9.2% vs. 22.9%, respectively (OR = 0.33; 95%CI: 0.29 to 0.39; I

Indexed as

CADcoronary artery diseaseCOVID-19novel coronavirussystematic review

Identifiers

PMID35205088
PMCPMC8868600

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.